Drew Lipke analyst STEPHENS

Currently out of the existing stock ratings of Drew Lipke, 2 are a BUY (25%), 6 are a HOLD (75%).

Drew Lipke

Work Performance Price Targets & Ratings Chart

Analyst Drew Lipke, currently employed at STEPHENS, has had 100% of price targets met with an average potential upside of 14.87%, reached in 295 days on average. Previously, Drew Lipke worked at BENCHMARK.

Drew Lipke has documented 16 price targets and ratings displayed on 7 stocks. The coverage is on Technology, Industrials sectors.

Most recent stock forecast was given on ESE, ESCO Technologies at 20-Aug-2018.

Wall Street Analyst Drew Lipke

Analyst best performing recommendations are on TXT (TEXTRON).
The best stock recommendation documented was for TXT (TEXTRON) on 10/23/2017. The price target of $60 was fulfilled within 95 days with a profit of $6.92 (13.04%), with a performance score of 1.37.

Average potential price target upside

ESE ESCO Technologies HEI Heico HXL Hexcel TDG Transdigm Group TXT Textron WWD Woodward CRZO Carrizo Oil & Gas

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Oct-2020

$300

$89.52 (42.53%)

$275

9 months 12 days ago
(09-Feb-2026)

9/9 (100%)

$31.2 (11.61%)

262

Buy Since 21-Oct-2024

$200

$190

1 years 6 months 12 days ago
(09-May-2025)

5/5 (100%)

$24.65 (14.06%)

62

Buy Since 05-Jan-2024

$99

2 years 10 months 16 days ago
(05-Jan-2024)

2/2 (100%)

$22.98 (30.23%)

248

Buy Since 16-Nov-2018

$74

$70

8 years 5 days ago
(16-Nov-2018)

2/2 (100%)

$7.13 (10.66%)

338

Hold Since 06-Dec-2017

$67

$65

8 years 3 months 1 days ago
(20-Aug-2018)

2/2 (100%)

$0.02 (0.03%)

126

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Drew Lipke?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?